How are you feeling today

 

  
 


Whenever we put up information on alternative treatments that have not been properly/Scientifically tested, we receive a few angry emails.
They say" we are trying to prevent people with cancer from getting effective treatment".
That is really not what we wish to do.
What concerns us is that potential treatments, like these on this page, are often sold for a great deal of money. And people with cancer can be vulnerable. It is understandable that patients or relatives will try anything if they think it might work. And that people really do want to believe that they work. But some alternative 'therapies' are just money making businesses targeting people who are sick and very vulnerable.
Our message is Be careful
Make sure you look into all the information that is available
Talk to your own cancer doctor before you buy

 
 
Alpha-Lipoic acid
 
CoQ10
L-Arginine
L-Lysine
Vitamin B-17
MSM
Niacin B3
Potasium
Quercetin
Selenium
Vit A
Vit C Oral
Vitamin D
Vit E
 
Zinc

Saw palmetto

Saw palmetto oil is an accepted medical treatment for benign prostatic hyperplasia (BPH) in New Zealand and in France, Germany, Austria, Italy, Spain, and other European countries.

Typical symptoms of BPH include difficulty starting urination, weak urinary stream, frequent urination, dribbling after urination, and waking up several times at night to urinate. Research suggests that saw palmetto can markedly improve all these symptoms. Benefits require approximately 4 to 6 weeks of treatment to develop. It appears that about two-thirds of men respond reasonably well.

Furthermore, while the prostate tends to continue to grow when left untreated, 1 saw palmetto causes a small but definite shrinkage. 2–4 In other words, it isn't just relieving symptoms, but may actually be retarding prostate enlargement. The drug Proscar does this too (and to even a greater extent than saw palmetto) but other standard medications for BPH have no effect on prostate size.

Research tells us that saw palmetto is equally effective to Proscar, but it has one great advantage: It leaves PSA (prostate-specific antigen) levels unchanged. Cancer raises PSA levels, and lab tests that measure PSA are used to screen for prostate cancer. Because Proscar lowers PSA measurements, its use may have the unintended effect of masking prostate cancer. Saw palmetto won't do this. On the other hand, Proscar has been shown to reduce the need for surgery, unlike saw palmetto or any of the other drugs used for BPH.

Saw palmetto also appears to be equally effective as another class of standard drugs known as alpha blockers, but may cause fewer side effects.

Note: Before self-treating with saw palmetto, be sure to get a proper medical evaluation to rule out prostate cancer.

Saw palmetto is also widely used to treat chronic prostatitis. An open trial that compared saw palmetto to the drug Proscar for the treatment of chronic nonbacterial prostatitis found that while the drug was effective, the herb was not. 5 However, these results do not mean that saw palmetto is ineffective for prostatis. Because this was an open study, researchers and participants knew who was getting saw palmetto and who was getting the drug. If there was any expectation that the drug would be more powerful than the herb, this in itself would be sufficient to skew the results toward that outcome.

Saw palmetto is sometimes recommended as a treatment for hair loss, but there is no evidence as yet that it is effective for this purpose.


References

1. Nickel JC. Placebo therapy of benign prostatic hyperplasia: a 25-month study. Br J Urol. 1988;81:383–387.

2. Braeckman J. The extract of Serenoa repens in the treatment of benign prostatic hyperplasia: a multicenter open study. Curr Ther Res. 1994;55:776–785.

3. Romics I, Schmitz H, Frang D. Experience in treating benign prostatic hypertrophy with Sabal serrulata for one year. Int Urol Nephrol. 1993;25:565–569.

4. Marks LS, Partin AW, Epstein JI, et al. Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia. J Urol. 2000;163:1451–1456.

5. Kaplan SA, Volpe MA, Te AE. A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome. J Urol. 2004;171:284-288.

6. Emili E, Lo Cigno M, Petrone U. Clinical trial of a new drug for treating hypertrophy of the prostate (Permixon) [in Italian]. Urologia. 1983;50:1042–1048.

7. Champault G, Patel JC, Bonnard AM. A double-blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasia. BrJ Clin Pharmacol. 1984;18:461–462.

8. Tasca A, Barulli M, Cavazzana A, et al. Treatment of obstructive symptomatology caused by prostatic adenoma using an extract of Serenoa repens. Double-blind clinical study vs. placebo [in Italian]. Minerva Urol Nefrol. 1985;37:87–91.

9. Boccafoschi C, Annoscia S. Comparison of Serenoa repens extract with placebo by controlled clinical trial in patients with prostatic adenomatosis [in Italian]. Urologia. 1983;50:1257–1268.

10. Smith HR, Memon A, Smart CJ, et al. The value of Permixon in benign prostatic hypertrophy. Br J Urol. 1986;58:36–40.

11. Descotes JL, Rambeaud JJ, Deschaseaux P, et al. Placebo-controlled evaluation of the efficacy and tolerability of Permixon in benign prostatic hyperplasia after exclusion of placebo responders. Clin Drug Invest. 1995;9:291–297.

12. Mattei FM, Capone M, Acconcia A, et al. Serenoa repens extract in the medical treatment of benign prostatic hypertrophy [in Italian]. Urologia. 1988;55:547–552.

13. Plosker GL, Brogden RN. Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia. Drugs Aging. 1996;9:379–395.

14. Carraro JC, Raynaud JP, Koch G, et al. Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patients. Prostate. 1996;29:231–240.

15. Debruyne F, Koch G, Boyle P, et al. Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a one-year randomized international study. Eur Urol. 2002;41:497-507.

16. Bach D. Medikamentose Langzeitbehandlung der BPH. Ergebnisse einer prospektiven 3-Jahres-Studie mit dem Sabalextrakt IDS 89. Urologe [B]. 1995;35:178–183.

17. Bach D, Schmitt M, Ebeling L. Phytopharmaceutical and synthetic agents in the treatment of benign prostatic hyperplasia (BPH). Phytomedicine. 1997;3:309–313.

18. Sokeland J. Combined sabal and urtica extract compared with finasteride in men with benign prostatic hyperplasia: analysis of prostate volume and therapeutic outcome. BJU Int. 2000;86:439–442.

19. Marks LS, Partin AW, Epstein JI, et al. Effects of a saw palmetto herbal blend in men with symptomatic benign prostatic hyperplasia. J Urol. 2000;163:1451–1456.

20. Gerber GS, Kuznetsov D, Johnson BC, et al. Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract symptoms. Urology. 2001;58:960–964.

21. Braeckman J, Bruhwyler J, Vandekerckhove K, et al. Efficacy and safety of the extract of Serenoa repens in the treatment of benign prostatic hyperplasia: therapeutic equivalence between twice and once daily dosage forms. Phytother Res. 1997;11:558–563.

22. Stepanov VN, Siniakova LA, Sarrazin B, et al. Efficacy and tolerability of the lipidosterolic extract of Serenoarepens (Permixon) in benign prostatic hyperplasia: a double-blind comparison of two dosage regimens. Adv Ther. 1999;16:231–241.

23. Plosker GL, Brogden RN. Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia. Drugs Aging. 1996;9:379–395.

24. Plosker GL, Brogden RN. Serenoa repens (Permixon). A review of its pharmacology and therapeutic efficacy in benign prostatic hyperplasia. Drugs Aging. 1996;9:379–395.

25. Bach D, Schmitt M, Ebeling L. Phytopharmaceutical and synthetic agents in the treatment of benign prostatic hyperplasia (BPH). Phytomedicine. 1997;3:309–313.

26. Cheema P, El-Mefty O, Jazieh AR. Intraoperative haemorrhage associated with the use of extract of saw palmetto herb: a case report and review of literature. J Intern Med. 2001;250:167-169.

27. Giannakopoulos X, Baltogiannis D, Giannakis D, et al. The lipidosterolic extract of Serenoa repens in the treatment of benign prostatic hyperplasia: a comparison of two dosage regimens. Adv Ther. 2002;19:285–296.

28. Feifer AH, Fleshner NE, Klotz L. Analytical accuracy and reliability of commonly used nutritional supplements in prostate disease. J Urol. 2002;168:150–154; discussion 154.

29. Willetts KE, Clements MS, Champion S, et al. Serenoa repens extract for benign prostate hyperplasia: a randomized controlled trial. BJU Int. 2003;92:267-70.

Saw Palmetto Extract 160mg 60sg SN0441 $NZ16.25

Secure order form

Other Payment Options
 
Beta Glucan
Cordyceps
 
Ellagic Acid
Lycopene
Resveratrol
Saw palmetto
TransferFactor
Life Force
Wellness Formular
Bromelain
Essential
Enzymes
Pancreatin
 
Colloidal Silver

Cancer cells hide after Chemotherapy and Radiation

After the initial doses of radiation and/or chemotherapy, cancer cells start hiding.
" They develop a slime coating, and they become like Stealth bombers, and they can hide from future doses of radiation and chemotherapy. This is why repeated dose of radiation and chemotherapy become less effective".Dr. John Maras, Nu-Gen Educational Library.

" The way to get rid of this "slime coating" is to use large doses of plant and animal enzymes- especially bromelain and pancreatin. This allows an 'access point' for the immune system to attack the cancer cells".....Dr. John Maras, Nu-Gen Educational Library

What doctors say about Chemo Therapy ?

 

 

"The world is a dangerous place to live; not because of the people who are evil, but because of the people who don't do anything about it."
Albert Einstein
A Sad day for Alternative healing

NOTICE: Due to FDA TGA MOH (plus other institutions with a vestige interest) regulations and various state laws, no medical claims can be made for alternative therapys and technology. All of the information expressed herein must be considered theoretical and unproven and for experimental research only

FAIR USE NOTICE: This may contain copyrighted (C ) material the use of which has not always been specifically authorized by the copyright owner. Such material is made available for educational purposes, to advance understanding of human rights, democracy, scientific, moral, ethical, and social justice issues, etc. It is believed that this constitutes a 'fair use' of any such copyrighted material as provided for in Title 17 U.S.C. section 107 of the US Copyright Law. This material is distributed without profit